Zhengye Biotechnology Holding (ZYBT) Short term Debt (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Short term Debt of $9.2 million for Q4 2025, down 11.43% year-over-year from $10.4 million in Q4 2024, and up 32680.78% quarter-over-quarter from $28000.0 in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Short term Debt (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Short term Debt for 3 consecutive years, with $9.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Short term Debt fell 11.43% year-over-year to $9.2 million; the TTM figure through Dec 2025 stood at $9.2 million (down 11.43% YoY), while the FY2025 annual figure was $9.3 million, down 8.73% from the prior year.
- Short term Debt rose to $9.2 million in Q4 2025 per ZYBT's latest filing, from $28000.0 in the prior quarter.
- Across five years, Short term Debt topped out at $11.1 million in Q4 2023 and bottomed at $28000.0 in Q2 2025.
- Historically, Short term Debt has averaged $7.7 million across 3 years, with a median of $9.8 million in 2024.
- Annual changes were most pronounced in 2024 — Short term Debt decreased 6.56% — and 2025, when it fell 11.43%.
- Zhengye Biotechnology Holding's Short term Debt stood at $11.1 million in 2023, then retreated by 6.56% to $10.4 million in 2024, then fell by 11.43% to $9.2 million in 2025.
- Business Quant data shows ZYBT's Short term Debt at $9.2 million in Q4 2025, $28000.0 in Q2 2025, and $10.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Zhengye Biotechnology Holding | 86.79 Mn | 79.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.18 Mn |
| Jun 30, 2025 | 28,000.00 |
| Dec 31, 2024 | 10.36 Mn |
| Dec 31, 2023 | 11.09 Mn |